Original language | English |
---|---|
Pages (from-to) | S1106-S1106 |
Number of pages | 1 |
Journal | Annals of Oncology |
Volume | 31 |
DOIs | |
Publication status | Published - Sep-2020 |
Event | ESMO Virtual Congress - Duration: 19-Sep-2020 → 18-Oct-2020 |
The clinical effect of concurrent oncogenic gene mutations in BRAF p.(V600E)-mutated NSCLC treated with dabrafenib and trametinib
P. Meng, B. Koopman, K. Kok, A. ter Elst, E. Schuuring, L. C. van Kempen, W. Timens, T. J. N. Hiltermann, H. J. M. Groen, A. van den Berg, A. J. van der Wekken
- Guided Treatment in Optimal Selected Cancer Patients (GUTS)
- Damage and Repair in Cancer Development and Cancer Treatment (DARE)
- Targeted Gynaecologic Oncology (TARGON)
- Groningen Research Institute for Asthma and COPD (GRIAC)
- Stem Cell Aging Leukemia and Lymphoma (SALL)
- Translational Immunology Groningen (TRIGR)
Research output: Contribution to journal › Meeting Abstract › Academic